Development and molecular characterization of hard-to-treat breast cancer pre-clinical models to enhance precision medicine

被引：0
|
作者：
Kuasne, Hellen
Fortier, Anne-Marie
Busque, Sandrine
Mathien, Simon
Savage, Paul
Ramirez, Constanza Martinez
Monast, Anie
Soleinova, Margarita
Omeroglu, Atilla
Asselah, Jamil
Bouganim, Nathaniel
Meterissian, Sarkis
Basik, Mark
Park, Morag
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P3-08-09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-08-09
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Receptor tyrosine kinase (RTK) targeting in pediatric high-grade glioma and diffuse midline glioma: Pre-clinical models and precision medicine
    Schwark, Kallen
    Messinger, Dana
    Cummings, Jessica R.
    Bradin, Joshua
    Kawakibi, Abed
    Babila, Clarissa M.
    Lyons, Samantha
    Ji, Sunjong
    Cartaxo, Rodrigo T.
    Kong, Seongbae
    Cantor, Evan
    Koschmann, Carl
    Yadav, Viveka Nand
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [32] Novel selective estrogen receptors degraders regress tumors in pre-clinical models of endocrine-resistant breast cancer
    Hager, J. H.
    Darimont, B.
    Joseph, J.
    Govek, S.
    Grillot, K.
    Aparicio, A.
    Bischoff, E.
    Kahraman, M.
    Kaufman, J.
    Lai, A.
    Lee, K-J
    Lu, N.
    Nagasawa, J.
    Prudente, R.
    Qian, J.
    Sensintaffar, J.
    Shao, G.
    Heyman, R.
    Rix, P.
    Smith, N. D.
    CANCER RESEARCH, 2012, 72
  • [33] Combination of BET Inhibition with Radiation Induces Anti Tumor Immune Response in Pre-Clinical Models of ERPositive Breast Cancer
    Vidal, C.
    Arbab, M.
    Rahimi, A. S.
    Alluri, P. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S42 - S42
  • [34] Recombinant Human Erythropoietin (rHuEPO) In Combination with Chemotherapy Increases Breast Cancer Metastasis In Pre-Clinical Mouse Models.
    Xenocostas, Anargyros
    Hedley, Benjamin D.
    Chu, Jenny E.
    Ormond, D. George
    Beausoleil, Michel
    Boasie, Alexandra
    Allan, Alison L.
    BLOOD, 2010, 116 (21) : 1370 - 1370
  • [35] New Approaches in Breast Cancer Therapy Through Green Nanotechnology and Nano-Ayurvedic Medicine - Pre-Clinical and Pilot Human Clinical Investigations
    Khoobchandani, Menka
    Katti, Kavita K.
    Karikachery, Alice Raphael
    Thipe, Velaphi C.
    Srisrimal, Deepak
    Kumar, Darsha
    Mohandoss, Dhurvas
    Darshakumar, Rashmi Dhurvas
    Joshi, Chintamani M.
    Katti, Kattesh, V
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2020, 15 : 181 - 197
  • [36] Pre-clinical development and molecular characterization of an engineered type 1 regulatory T-cell product suitable for immunotherapy
    Liu, Jeffrey Mao-Hwa
    Chen, Ping
    Uyeda, Molly Javier
    Cieniewicz, Brandon
    Sayitoglu, Ece Canan
    Thomas, Benjamin Craig
    Sato, Yohei
    Bacchetta, Rosa
    Cepika, Alma-Martina
    Roncarolo, Maria Grazia
    CYTOTHERAPY, 2021, 23 (11) : 1017 - 1028
  • [37] Development of organoid raft cultures of cervical, breast and glioblastoma tumors as quick economical ex vivo human cancer models for pre-clinical drug evaluation.
    Banerjee, Nilam Sanjib
    Moore, Dianne W.
    Gangrade, Abhisek
    Buchsbaum, Donald J.
    Nabors, Luise Burt
    Broker, Thomas R.
    Chow, Louise T.
    CANCER RESEARCH, 2021, 81 (13)
  • [38] A novel class of selective estrogen receptors degraders regresses tumors in pre-clinical models of endocrine-resistant breast cancer
    Joseph, James D.
    Darimont, Beatrice
    Govek, Steven
    Brigham, Dan
    Qian, Jing
    Sensintaffar, John
    Shao, Gang
    Aparicio, Anna
    Kahraman, Mehmet
    Lai, Andiliy
    Lee, Kyoung-Jin
    Lu, Nhin
    Nagasawa, Johnny
    Moon, Michael
    Rix, Peter
    Smith, Nick
    Hager, Jeff
    CANCER RESEARCH, 2014, 74 (19)
  • [39] Combination of CTx-0294945 a highly selective inhibitor of focal adhesion kinase with bevacizumab in pre-clinical models of breast cancer
    Street, I.
    de Sylva, M.
    Lackovic, K.
    Ganame, D.
    Holloway, G.
    Anderson, R.
    McArthur, G.
    Natoli, A.
    Doherty, J.
    Falk, H.
    Kersten, W.
    Lessene, R.
    Leuchowius, K.
    Novello, P.
    Yang, H.
    Bergman, Y.
    Camerino, M.
    Charman, S.
    Gregg, A.
    Choi, N.
    Foitzik, R.
    Hemley, C.
    Lunniss, G.
    Nikac, M.
    Walker, S.
    Lovrecz, G.
    Monahan, B.
    Peat, T.
    Robinson, C.
    Scott, C.
    Gorman, M.
    Parker, M.
    Holmes, I.
    Devlin, M.
    CANCER RESEARCH, 2012, 72
  • [40] A novel class of selective estrogen receptors degraders regresses tumors in pre-clinical models of endocrine-resistant breast cancer
    Darimont, Beatrice
    Govek, Steven
    Lu, Nihn
    Nagasawa, Johnny
    Prudente, Rene
    Qian, Jing
    Sensintaffar, John
    Shao, Gang
    Heyman, Richard
    Rix, Peter
    Smith, Nicholas
    Hager, Jeffrey
    Joseph, James
    Grillot, Katherine
    Aparicio, Anna
    Bischoff, Eric
    Kahraman, Mehmet
    Kaufman, Josh
    Lai, Andiliy
    Lee, Kyoung-Jin
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
12345